Merck (MRK) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

In vaccines, sales of HPV vaccines — Gardasil and Gardasil 9 ... Merck’s pneumococcal 15-valent conjugate vaccine, were $161 million, down 9%, primarily due to lower demand in the United ...

Merck’s new 21-valent pneumococcal ... Excluding sales of Gardasil in China in 2024 and 2025 and the negative impact of currency, revenues are expected to rise 7% to 9%. The earnings per share ...

GARDASIL 9 is a vaccine that helps protect against disease caused by the following types of Human Papillomavirus (HPV): 6, 11, 16, 18, 31, 33, 45, 52 and 58. For more information, see Section 1.

A federal judge ruled in favor of Merck in litigation accusing it of concealing the risks of Gardasil, a vaccine to prevent ...

A federal judge ruled in favor of Merck in litigation accusing it of concealing the risks of Gardasil, a vaccine to prevent ...

The message was apparently designed to fit a broader push in China to boost male vaccination against HPV-related diseases following Gardasil’s local approval earlier this year in males aged 9 to 26.

Merck (NYSE:MRK) and a plaintiff who is suing the drugmaker over allegations that the Gardasil HPV vaccine she received as a teen caused her heart issues and nerve pain have agreed to adjourn the ...

It's the most common sexually transmitted infection, but it's also preventable thanks to the vaccine Gardasil-9. Yet online, misinformation runs rampant about the vaccine, which is also known for ...